Agilent Technologies, Inc. (NYSE: A) has entered a definitive agreement to acquire Genohm, a privately held company. Genohm develops on-premise, highly differentiated, cloud-based software solutions for laboratory management. Genohm is also a featured sponsor of Biobanking.com.
With over 50 years of insight and innovation Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets. Customers trust Agilent instruments, software, services, solutions and employees to provide answers to their most challenging questions. Agilent employs 14,200 people worldwide and generated revenues of $4.47 billion in the 2017 fiscal year.
Genohm was originally founded in Ghent, Belgium in 2002 as a small two-person bio-informatics shop. Today, Genohm has a head office in Lausanne, with others in Ghent, and Durham NC and a workforce of more than 40 highly trained software and life sciences engineers. The company aims to guarantee compliance, traceability and data management for big labs with continuously evolving requirements. Genohm officially entered the lab informatics market with the successful launch of its main laboratory software automation suite, SLIMS. The software serves a rapidly growing set of customers in a wide range of research and clinical environments throughout Europe, the Middle East, Asia Pacific and the USA.
Genohm’s SLIMS is a digital platform that provides laboratories with a seamless laboratory information management system (LIMS) and electronic lab notebook (ELN) that is rapidly deployable. It is used in biobanks, research labs and next generation sequencing facilities. From the initial goods received shipment to the raw data to in-silico analysis pipelines the digital environment tracks data and samples, tests and users, results and workflows. An application marketplace with preconfigured workflows is on offer to enable rapid system implementation across a broad range of industries and science workflows.
The acquisition enhances Agilent’s current software portfolio, adding LIMS and workflow management, and expanding the ELN capability. This combination should allow Agilent to bring greater context to analytical data, enabling scientists to generate results more efficiently. The transaction is subject to closing conditions. Financial terms of the deal are not being disclosed.